← Open Payments lookup

JANETTE MCDOUGALL: Open Payments

NPI 1134764012 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,860 in 80 payments from 18 companies in 2025. Trend: 2023 $623 · 2024 $1,346 · 2025 $1,860

Food & beverage: $1,756Education: $60Consulting: $44
CompanyPaymentsAmount
GlaxoSmithKline, LLC.14$264
Takeda Pharmaceuticals U.S.A., Inc.11$224
Regeneron Healthcare Solutions, Inc.14$194
Novartis Pharmaceuticals Corporation7$164
Pharming Healthcare, Inc.6$150
ARS Pharmaceuticals Operations, Inc.5$142
BioCryst US Sales Co., LLC5$134
ABBVIE INC.1$113
Cycle Pharmaceuticals Inc4$96
GENZYME CORPORATION2$73

Products named: DUPIXENT, NUCALA, RUCONEST, NEFFY, ORLADEYO, BOTOX, TRELEGY ELLIPTA, XOLAIR.

Industry payments across NV — which companies pay providers there.